中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
27期
117-119
,共3页
神经节苷脂%纳洛酮%新生儿%缺氧缺血性脑病%疗效
神經節苷脂%納洛酮%新生兒%缺氧缺血性腦病%療效
신경절감지%납락동%신생인%결양결혈성뇌병%료효
Gangliosides%Naloxone%Newborns%Hypoxic-ischemic encephalopathy%Efficacy
目的 研究分析神经节苷脂联合纳洛酮治疗新生儿缺氧缺血性脑病的临床效果. 方法 随机选取2012年9月-2014年9月该院收治的70例新生儿缺氧缺血性脑病患者,随机分为对照组、观察组,各35例. 对照组给予常规治疗,观察组给予神经节苷脂联合纳洛酮治疗,比较分析两组的临床治疗有效率和新生儿神经行为测定评分(NBNA)情况. 结果 观察组临床治疗总有效率为97.14%,明显高于对照组的77.14%,差异有统计学意义(P<0.05);观察组治疗第5、10天NBNA评分显著高于对照组,差异有统计学意义(P<0.01). 结论 神经节苷脂联合纳洛酮治疗新生儿缺氧缺血性脑病具有较高的临床治疗效果,能够有效提高临床疗效,改善患儿病情,值得推广.
目的 研究分析神經節苷脂聯閤納洛酮治療新生兒缺氧缺血性腦病的臨床效果. 方法 隨機選取2012年9月-2014年9月該院收治的70例新生兒缺氧缺血性腦病患者,隨機分為對照組、觀察組,各35例. 對照組給予常規治療,觀察組給予神經節苷脂聯閤納洛酮治療,比較分析兩組的臨床治療有效率和新生兒神經行為測定評分(NBNA)情況. 結果 觀察組臨床治療總有效率為97.14%,明顯高于對照組的77.14%,差異有統計學意義(P<0.05);觀察組治療第5、10天NBNA評分顯著高于對照組,差異有統計學意義(P<0.01). 結論 神經節苷脂聯閤納洛酮治療新生兒缺氧缺血性腦病具有較高的臨床治療效果,能夠有效提高臨床療效,改善患兒病情,值得推廣.
목적 연구분석신경절감지연합납락동치료신생인결양결혈성뇌병적림상효과. 방법 수궤선취2012년9월-2014년9월해원수치적70례신생인결양결혈성뇌병환자,수궤분위대조조、관찰조,각35례. 대조조급여상규치료,관찰조급여신경절감지연합납락동치료,비교분석량조적림상치료유효솔화신생인신경행위측정평분(NBNA)정황. 결과 관찰조림상치료총유효솔위97.14%,명현고우대조조적77.14%,차이유통계학의의(P<0.05);관찰조치료제5、10천NBNA평분현저고우대조조,차이유통계학의의(P<0.01). 결론 신경절감지연합납락동치료신생인결양결혈성뇌병구유교고적림상치료효과,능구유효제고림상료효,개선환인병정,치득추엄.
Objective To study the analysis ganglioside combined with naloxone treatment of neonatal hypoxic-ischemic en-cephalopathy clinical results. Methods From September 2012 to September 2014 in our hospital 70 cases of neonatal hypoxic-is-chemic encephalopathy were randomly divided into two groups, the observation group, 35 cases each. The control group received conventional treatment, observation group ganglioside combined with naloxone, comparative analysis of the two groups of clinical effectiveness and neonatal behavioral neurological assessment scores (NBNA) situation. Results The clinical total effective rate was 97.14%, significantly higher than 77.14%, the difference was significant (P <0.05); 5 and 10 days of observation group NBNA scores were significantly higher, the difference was significant (P <0.01). Conclusion Ganglioside combined with naloxone treat-ment of neonatal hypoxic-ischemic encephalopathy have high clinical effect, can effectively improve the clinical efficacy and im-prove the condition of children, worthy of promotion.
